Valuation (78%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.51 | N/A |
| PEG Ratio (TTM) | -0.68 | N/A |
| P/S Ratio (TTM) | 4.14 | N/A |
| P/B Ratio (TTM) | 0.91 | N/A |
| P/FCF Ratio (TTM) | 10.37 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.61 | N/A |
| Price to 5YR AVG FCF Ratio | 13.37 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.49% | N/A |
| ROE (TTM) | 7.81% | N/A |
| Net Profit Margin (TTM) | 35.94% | N/A |
| ROIC 5YR AVG | 5.27% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 10.29% | -10.32% | 109.70% |
| Revenue | 30.46% | 49.64% | 42.42% |
| Net Income | 9.82% | 50.89% | 143.05% |
| Cash Flow | 67.78% | -7.47% | 55.17% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.92 | N/A |
| Quick Ratio (TTM) | 0.92 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 2.01 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.63 | N/A |
| LTL to 5YR AVG FCF | 18.03 | N/A |
| Shares Outstanding Growth 5YR AVG | 41.07% | N/A |